Incyte Corp (INCY)

Add to Watchlists

Create an Alert

Quickflows

80.31 +2.81 +3.63% NASDAQ Mar 5, 16:59 USD

Incyte News

Wire

Headline

Time (ET)
Yahoo

Biotech Stock Roundup: REGN, VIR's COVID-19 Updates, KMPH's Drug Approval & More

03/04 14:47
Yahoo

Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder

03/03 09:43
MT Newswires

Eli Lilly, Incyte Say Baricitinib Meets Phase 3 Efficacy Endpoint in Treating Baldness

03/03 08:53
SA Breaking News

Lilly, Incyte's baricitinib shows hair regrowth in late-stage alopecia areata study

03/03 07:04
PR Newswire

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial

03/03 06:45
MT Newswires

Incyte's Anal Cancer Drug Receives EMA Validation

02/26 05:25
SA Breaking News

Incyte's retifanlimab application validated in Europe for anal cancer

02/26 04:39
Business Wire

Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)

02/26 03:00
Yahoo

Top Healthcare Stocks for March 2021

02/24 16:11
MT Newswires

Incyte Says FDA Grants Priority Review to Supplemental New Drug Application for Jakafi

02/22 11:02
Yahoo

Incyte Says FDA Grants Priority Review For Eczema Cream; Street Sees 20% Upside

02/22 09:18
Yahoo

Incyte Announces Acceptance and Priority Review of sNDA for Jakafi® (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease

02/22 08:00
SA Breaking News

FDA accepts Incyte's ruxolitinib NDA with Priority Review

02/19 09:26
MT Newswires

Incyte's New-Drug Application for Ruxolitinib Cream for Atopic Dermatitis Accepted for Priority Review by FDA

02/19 08:42
Yahoo

Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis

02/19 08:00
MT Newswires

MacroGenics Receives $10 Million Milestone Payment From Incyte Under Retifanlimab Deal

02/11 09:38
Yahoo

The Zacks Analyst Blog Highlights: Biogen, Gilead Sciences, Regeneron Pharma, Bristol-Myers Squibb and Incyte

02/11 09:13
Yahoo

Incyte to Present at Upcoming Investor Conference

02/11 08:00
Yahoo

Update: Incyte (NASDAQ:INCY) Stock Gained 14% In The Last Five Years

02/11 03:06
Yahoo

Biotech Stock Roundup: Q4 Results of BMY, REGN, BIIB & Other Regulatory Updates

02/10 11:57

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.